# US 2026/0298828 A1 · Methods of acquiring microscopic images of biological samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0298828 A1
- Document ID: US20260298828A1
- Status: Published application
- Kind: A1
- Application number: 19/480,886
- Filed: 2024-05-03
- Published: 2026-10-01
- Earliest claimed: 2023-05-04
- Assignees: Yale University
- Applicants: Yale University
- Inventors: Antonio Giraldez; Mark Pownall
- Web page: https://patentgrep.com/patent/US20260298828A1

## CPC

- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- G01N 1/36: Embedding or analogous mounting of samples
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Described herein is a method of acquiring a microscopic image of a biological sample. In certain embodiments, the method includes at least one of the following: the method including: embedding the biological sample in a first swellable hydrogel; expanding the first swellable hydrogel and the biological sample embedded therein to obtain a first expanded biological sample; embedding the first expanded biological sample in a second swellable hydrogel; labeling a DNA molecule in a chromatin in the biological sample with a first dye; expanding the second swellable hydrogel and the first expanded biological sample embedded therein to obtain a second expanded biological sample; acquiring the microscopic image of the second expanded biological sample with a light microscopy technology. Also described is a method of evaluating the effect of a treatment of a biological sample using the imaging method.

## Claims

### Claim 1

A method of acquiring a microscopic image of a biological sample, the method comprising:
embedding the biological sample in a first swellable hydrogel;
expanding the first swellable hydrogel and the biological sample embedded therein to obtain a first expanded biological sample;
embedding the first expanded biological sample in a second swellable hydrogel;
labeling a DNA molecule in a chromatin in the biological sample with a first dye;
expanding the second swellable hydrogel and the first expanded biological sample embedded therein to obtain a second expanded biological sample; and
acquiring a microscopic image of the second expanded biological sample with light microscopy technology, wherein the acquired microscopic image includes the labeled chromatin.

### Claim 2 (depends on 1)

The method of claim 1, wherein the first swellable hydrogel or the second swellable hydrogel is a polyacrylamide-based hydrogel.

### Claim 3 (depends on 1)

The method of claim 1, wherein embedding the biological sample in the first swellable hydrogel comprises crosslinking the biological sample to the first swellable hydrogel.

### Claim 4 (depends on 1)

The method of claim 1, wherein at least one of the following applies:
a first linear expansion factor of the biological sample in the expansion of the first swellable hydrogel is 3 or more,
a second linear expansion factor of the first expanded biological sample in the expansion of the second swellable hydrogel is 3 or more,
a combined linear expansion factor of the biological sample in the expansions of the first swellable hydrogel and the second swellable hydrogel is 10 or more.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method of claim 1, wherein labeling the DNA molecule in the chromatin with the first dye comprises attaching the first dye to the DNA molecule via a covalent linker.

### Claim 7 (depends on 1)

The method of claim 1, further comprising: introducing into the DNA molecule in the chromatin a modified nucleoside for attaching the first dye covalently,
optionally wherein the modified nucleoside is introduced into the DNA molecule metabolically.

### Claim 8

(canceled)

### Claim 9 (depends on 7)

The method of claim 7, wherein the modified nucleoside comprises 2′-deoxy-2′-fluoro-5-ethynyluridine (F-ara-EdU), 5-ethynyl-2′-deoxyuridine (EdU), 5-Ethynyl-2′-deoxycytidine (5-EdC), bromodeoxyuridine (BrdU), or azidomethyl-2′-deoxyuridine (AmdU).

### Claim 10 (depends on 1)

The method of claim 1, wherein the first dye is attached to the DNA molecule using a click reaction.

### Claim 11 (depends on 1)

The method of claim 1, wherein the first dye comprises an azide group and the DNA comprises an alkyne group or wherein the first dye comprises an alkyne group and the DNA comprises an azide group, and wherein the covalent linker is formed by a click reaction between the azide group and the alkyne group.

### Claim 12 (depends on 1)

The method of claim 1, further comprising labeling a protein or an RNA molecule associated with the chromatin, wherein the microscopic image includes the labeled protein or the labeled RNA molecule.

### Claim 13 (depends on 12)

The method of claim 12, wherein at least one of the following applies:
the protein is labeled, and the protein comprises a histone, a transcription factor, a polymerase, a nuclease, or DNA-binding portions thereof;
the protein is labeled by an antibody;
the RNA molecule is labeled, and the RNA molecule is labeled by a second dye;
the RNA molecule is labeled and is a transcription product of the DNA molecule in the chromatin.

### Claim at position 14

14-16. (canceled)

### Claim 17 (depends on 1)

The method of claim 1, which detects one or more sequences in the DNA molecule.

### Claim 18 (depends on 17)

The method of claim 17, wherein the method comprising labeling the one or more sequences in the DNA molecule with a probe that binds to the one or more sequences specifically.

### Claim 19 (depends on 18)

The method of claim 18, wherein the probe comprises a protein or a nucleic acid,
optionally wherein the probe comprises:
a nucleic acid that binds to the one or more sequences specifically; and
a protein that binds to the nucleic acid, or a protein that binds to a complex formed by the nucleic acid and the one or more sequences of the DNA molecule.

### Claim 20

(canceled)

### Claim 21 (depends on 18)

The method of claim 18, wherein the method directly visualizes the one or more sequences using a hybridization chain reaction (HCR) in situ hybridization method,
optionally wherein the probe comprises:
a single guide RNA (sgRNA) that binds to the one or more sequences specifically; and
a Cas protein that binds to a complex formed by the sgRNA and the one or more sequences,
optionally wherein the Cas is a catalytically dead Cas protein.

### Claim at position 20

22-23. (canceled)

### Claim 24 (depends on 1)

A method of evaluating effect of a treatment of a biological sample, the method comprising:
preparing a first biological sample and a second biological sample;
subjecting the first biological sample to the treatment without subjecting the second biological sample to the treatment;
acquiring a first microscopic image of the first biological sample and a second microscopic image of the second biological sample with the method of claim 1;
comparing the first microscopic image with the second microscopic image.

### Claim 25 (depends on 23)

The method of claim 23, wherein the treatment comprises administration of a compound to a subject and wherein the biological sample is within the subject.

### Claim 26 (depends on 24)

The method of claim 24, wherein at least one of the following applies:
comparing the first microscopic image with the second microscopic image comprises comparing a chromatin structure, a transcription activity, a DNA replication activity, a DNA damage, a DNA repair, or a DNA-protein interaction between the first microscopic image and the second microscopic image,
the first biological sample and the second biological sample are samples obtained from a subject, and the method evaluates the effect of the administration of a pharmaceutical compound to the first biological sample.

### Claim 27

(canceled)
